Mark Gigantone

Mark Gigantone is an accomplished professional in the field of clinical operations and development, currently serving as Associate Director, Clinical Operations – Program Lead at Gilead Sciences since September 2022. Prior experience includes roles as Associate Director, Clinical Development at Elpiscience Biopharmaceuticals, Inc., and Associate Director, Clinical Operations at Daiichi Sankyo, Inc. Mark has also held significant positions at Novartis Oncology, where titles included Expert Global Trial Manager and Sr. Clinical Research Scientist, and at Warner Chilcott as Manager, Clinical Studies and Clinical Research Associate. Mark began the career at ImClone Systems, focusing on protein purification. Educational qualifications include a BS in Biotechnology from Rutgers University and an MS in Management from Stevens Institute of Technology.